FLUID INFUSION SYSTEM THAT AUTOMATICALLY DETERMINES AND DELIVERS A CORRECTION BOLUS
Patent №
US 11,660,394
Granted
2023-05-30
Filed 2020
Owner
MEDTRONIC MINIMED, INC.
Lab
—
AI components
1
planning
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
17122445
A method of controlling an insulin infusion device involves controlling the device to operate in an automatic basal insulin delivery mode, obtaining a blood glucose measurement for the user, and initiating a correction bolus procedure when: the measurement exceeds a correction bolus threshold value; and a maximum basal insulin infusion rate is reached during the automatic basal insulin delivery mode. The correction bolus procedure calculates an initial correction bolus amount, and scales the initial amount to obtain a final correction bolus amount, such that a predicted future blood glucose level resulting from simulated delivery of the final correction bolus amount exceeds a low blood glucose threshold level. The final amount is delivered to the user during operation in the automatic basal insulin delivery mode.
AI classification
Ownership
MEDTRONIC MINIMED, INC.
assignment · 546530203
Assignors
LINTEREUR, LOUIS J., ROY, ANIRBAN, GROSMAN, BENYAMIN, WEYDT, PATRICK E., PARIKH, NEHA J., WU, DI, DIANATY, ALI
On an employer assignment, the assignors are typically the inventors.